Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BVMF/GILD34 stock hub

BVMF/GILD34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/GILD34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

798.6B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/GILD34

In the news

Latest news · BVMF/GILD34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.3P50 14.6P75 19.6

Trailing P/E16.6

P25 15.2P50 21.5P75 27.3

ROE43.4

P25 5.3P50 12.3P75 22.5

ROIC27.7

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/GILD34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

227

Groups with data

Currency

USD

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	17,000
Employees Change	-400%
Employees Change Percent	-2.22
Enterprise value	BRL 853.9B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	BRL 798.6B
Price	BRL 322
Price currency	BRL
Rev Per Employee	9,124,972.62x
Sector	Healthcare
Sic	2836
Symbol	bvmf/GILD34
Website	https://www.gilead.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.02%
EV Earnings	17.76x
EV/EBIT	14.55x
EV/EBITDA	11.7x
EV/FCF	16x
EV/Sales	5.86x
FCF yield	6.68%
P/B ratio	6.53x
P/E ratio	16.61x
P/S ratio	5.15x
PE Ratio10 Y	73.41x
PE Ratio3 Y	123.96x
PE Ratio5 Y	81.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	40.3%
EBITDA Margin	49.56%
FCF margin	34.4%
Gross margin	79.37%
Gross Profit	BRL 123.1B
Gross Profit Growth	4.91%
Gross Profit Growth Q	7.57%
Gross Profit Growth3 Y	3.3%
Gross Profit Growth5 Y	1.9%
Net Income	BRL 48.1B
Net Income Growth	54.5%
Net Income Growth Q	53.69%
Net Income Growth3 Y	18.18%
Net Income Growth5 Y	98.24%
Pretax Margin	36.07%
Profit Margin	30.99%
Profit Per Employee	BRL 2.8M
ROA	13.29
Roa5y	10.85
ROCE	25.61
ROE	43.36
Roe5y	24.33
ROIC	27.7
Roic5y	21.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	11.04%
Cagr1y	20.5%
Cagr3y	21.11%
Cagr5y	16.55%
Div CAGR3	3.29%
Div CAGR5	2.69%
EPS Growth	55.43
EPS Growth Q	54.81
EPS Growth3 Y	18.49
EPS Growth5 Y	98.31
FCF Growth	3.92%
FCF Growth Q	46.82%
FCF Growth3 Y	6.85%
FCF Growth5 Y	3.3%
OCF Growth	4.25%
OCF Growth Q	44.79%
OCF Growth10 Y	-5.37%
OCF Growth3 Y	6.38%
OCF Growth5 Y	2.95%
Revenue Growth	3.48x
Revenue Growth Q	4.4x
Revenue Growth3 Y	3.21x
Revenue Growth5 Y	3.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.53
Assets	BRL 293.6B
Cash	BRL 51.2B
Current Assets	BRL 91.6B
Current Liabilities	BRL 46.6B
Debt	BRL 115.7B
Debt EBITDA	BRL 1.49
Debt Equity	BRL 0.95
Debt FCF	BRL 2.17
Equity	BRL 122.2B
Interest Coverage	11.94
Liabilities	BRL 171.4B
Long Term Assets	BRL 202B
Long Term Liabilities	BRL 124.8B
Net Cash	BRL -59.3B
Net Cash By Market Cap	BRL -7.43
Net Debt EBITDA	BRL 0.77
Net Debt Equity	BRL 0.49
Net Debt FCF	BRL 1.11
Tangible Book Value	BRL -6.2B
Tangible Book Value Per Share	BRL -4.96
WACC	6.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.97
Inventory Turnover	3.34
Net Working Capital	BRL 3.4B
Quick ratio	1.54
Working Capital	BRL 47.8B
Working Capital Turnover	BRL 22.61

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.34%
Dividend Growth	-3.96%
Dividend Growth Years	2%
Dividend per share	BRL 5.78
Dividend Years	11
Dividend Yield	1.79%
Ex Div Date	2026-03-12
Last Dividend	BRL 1.45
Payout Frequency	Quarterly
Payout Ratio	43.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	184.9%
1Y total return	20.49%
200-day SMA	317.6
3Y total return	77.68%
50-day SMA	350.2
50-day SMA vs 200-day SMA	50over200
5Y total return	115.08%
All Time High	396.4
All Time High Change	-16.32%
All Time High Date	2026-02-09
All Time Low	102.3
All Time Low Change	224.25%
All Time Low Date	2017-05-15
ATR	7.6
Beta	0.4
Ch YTD	-3.58
High	322.3
High52	396.4
High52 Date	2026-02-09
High52ch	-18.69%
Low	321.1
Low52	273.5
Low52 Date	2025-05-09
Low52ch	17.84%
Ma50ch	-5.28%
Price vs 200-day SMA	4.43%
RSI	34.66
RSI Monthly	56.62
RSI Weekly	48.05
Sharpe ratio	1.36x
Sortino ratio	2.32
Total Return	2.13%
Tr YTD	-3.21
Tr1m	-9.2%
Tr1w	0.3%
Tr3m	-15.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 62.5B
Operating Income Growth	9.44
Operating Income Growth Q	6.55
Operating Income Growth3 Y	5.45
Operating Income Growth5 Y	0.53
Operating margin	40.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,239,252,307%
Net Borrowing	-13,720,446,400
Shares Insiders	0.1%
Shares Institutions	89.54%
Shares Qo Q	0.08%
Shares Yo Y	-0.34%
Short Ratio	3.53

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 48.7B
Average Volume	118.35x
Bv Per Share	98.77
CAPEX	BRL -3B
Ch10y	119.3
Ch1m	-9.2
Ch1w	0.3
Ch1y	18.39
Ch3m	-16.13
Ch3y	65.88
Ch5y	89.64
Ch6m	0.7
Change	-2.83%
Change From Open	0.37
Close	331.7
Days Gap	-3.19
Depreciation Amortization	13,528,792,600
Dollar Volume	19,659.7
Earnings Date	2026-05-07
EBIT	BRL 62.5B
EBITDA	BRL 76.9B
EPS	BRL 38.36
F Score	8
FCF	BRL 53.4B
FCF EV Yield	6.25x
Financing CF	-44,644,732,550
Fiscal Year End	December
Founded	1,987
Goodwill	40,856,658,800
Graham Number	146.75208
Graham Upside	-54.47
Income Tax	BRL 7.9B
Investing CF	-13,605,218,800
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	BRL 485
Lynch Upside	50.51
Ma150	323.1
Ma150ch	2.66%
Ma20	362.7
Ma20ch	-8.56%
Net CF	-1,549,367,325
Next Earnings Date	2026-08-06
Open	321.1
P FCF Ratio	14.96
P OCF Ratio	14.17
Payment Date	2026-04-06
Position In Range	100
Ppne	27,706,259,600
Price Date	2026-05-08
Price EBITDA	BRL 10.39
Relative Volume	0.52x
Revenue	155,124,534,600x
SBC By Revenue	3.04x
Share Based Comp	4,710,702,675
Tax By Revenue	5.08x
Tax Rate	14.09%
Tr6m	1.54%
Volume	61
Z Score	4.51

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/GILD34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$5.78 annual per share

Payout ratio

+43.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+2.7%

2 consecutive years of growth

Total shareholder yield

+2.1%

Next ex-dividend date: 2026-03-12

Performance

BVMF/GILD34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/GILD34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+89.5%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/GILD34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.7

Neutral momentum band

Price vs 200-day MA

+4.4%

50/200-day relationship not available

Beta (5Y)

0.40

Less volatile than the market

Sharpe ratio

1.36

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/GILD34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/GILD34 stock rating?

bvmf/GILD34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/GILD34 analysis?

The full report lives at /stocks/bvmf/GILD34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/GILD34?

The latest report frames bvmf/GILD34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/GILD34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.